🔴 Nasus Pharma is trading 10% down in after-hours trading; catalyst remains unclear

Nasus Pharma is trading at $3.00, down 10.04% after hours; the catalyst for the October 21 decline remains unclear.

• No company-specific announcement explaining the decline was identified. The latest release on Nasus Pharma’s investor-news page, dated September 29, concerns enrollment of the first patient in its NS003 Phase 1 study.
• Major U.S. indices were up, so broad-market direction does not explain the opposite move.